News Archive

5th Nov 2009 - AIMSPRO receives US orphan-drug designation for ALS

29th Sep 2009 - Ceremben Permit Approved

22nd Jul 2009 - Patent granted by the OAPI

2nd Jun 2009 - Health Director Article: Krabbe’s disease and Orphan Status

2nd Jun 2009 - Health Director Article: Harmonisation Helps

2nd Jun 2009 - Health Director Article: Anatomy of the Clinical Trial application process

19th May 2009 - AIMSPRO designated as an orphan drug

14th May 2009 - Ceremben granted an Equine Research Permit

5th May 2009 - Thanks to the trustees of Jakafraik Properties Limited

3rd Mar 2009 - Daval investigation concluded

16th Jan 2009 - Ceremben to be submitted to field trialling.

10th Dec 2008 - Recruitment commenced

18th Apr 2008 - Clinical Trial Authorisation

20th Mar 2008 - Multiple Sclerosis Trial

17th Mar 2008 - Decision on Terminated Clinical Trial

25th Feb 2008 - Notice to shareholders

18th Feb 2008 - Horse Trial Approval

16th Jan 2008 - Listing

15th Jan 2008 - Launch of Ceremben

14th Jan 2008 - Approval for two studies

20th Dec 2007 - Accepted for Membership of the Association of the British Pharmaceutical Industry

9th Oct 2007 - Trials

29th Nov 2006 - 2006 Annual General Meeting

25th Nov 2006 - High Court Claim

24th Oct 2006 - "Aimspro" in Mexico

22nd May 2006 - Internet prescriptions